This study was designed to determine whether Coxsackie adenovirus receptor (CAR) and anb3/anb5 integrin co-receptors are involved in adenovirus gene transfer in the rat cochlea. We find that CAR and integrin co-receptors are expressed in every cell subtype transduced by the adenoviral vector Ad5 DE1-E3/cytomegalovirus/green fluorescent protein (GFP) on cochlear slices in vitro. The spiral ganglion neurons, which do not express CAR, were not transduced by the virus. Blocking these receptors by monoclonal antibodies decreased transgene expression, whereas disrupting tight junctions with ethylenediaminetetraacetic acid led to an increased transgene expression. However, sensory hair cells and strial cells also expressing CAR and an integrins were not transduced by the vector.
Introduction
Gene transfer has become a powerful molecular tool for neuroscience research and is a potential treatment for human diseases. Replication-deficient adenoviral vectors based on human serotype 5 have been shown to transduce the mammalian inner ear efficiently both in vitro 1,2 and in vivo. [3] [4] [5] In vivo, some studies have shown that the most efficient transduction is seen in mesothelial cells lining the perilymphatic fluids, whereas the sensory hair cells of the organ of Corti and the spiral ganglion neurons are not transduced. 6, 7 However, other studies have demonstrated that adenovirus vectors can indeed transduce sensory hair cells in the organ of Corti. [8] [9] [10] So far, no explanation has been provided to explain this discrepancy.
Coxsackie adenovirus receptor (CAR) is the primary attachment receptor of all adenoviruses except subgroup B.
11 Adenovirus transduces cells by competitive heterophilic interaction between its fiber-knob and CAR, leading to tight junction disruption. 12, 13 Virus uptake is mediated by binding of the capsid penton-base with the an subunit from co-receptors anb3 or anb5 integrins. 14 Adenoviral receptors are expressed in a wide range of cell subtypes and gene delivery is a function of the expression level of these receptors. [15] [16] [17] Only one study concerns the expression and the localization of adenoviral receptors in the mammalian cochlea, 18 and no data have been reported after application of adenovirus in the rat cochlea in vivo.
This study examines the expression and cellular localization of CAR, and an, b3 and b5 integrins in the rat cochlea by PCR and immunocytochemistry. Adenovirus viral entry pathways were studied by improving or blocking access to the receptors on cochlear slices from postnatal rats as well as in adult rat cochleas in vivo. The effects of different techniques of virus administration on the distribution of green fluorescent protein (GFP) expression and any adverse effects were also studied using this new model of rat cochlea in vivo.
Results

CAR and an, b3 and b5 integrin expression in rat cochlea
The presence of mRNAs coding for CAR and coreceptors an, b3 and b5 integrins was determined by using a PCR strategy on P2 and P14 rat cochlear cDNA libraries. DNA fragments were obtained at the expected size for the specific primers ( Figure 1a ) and their identity was ascertained by DNA extraction and sequencing. These results demonstrate that mRNAs coding for CAR and an, b3 and b5 integrin co-receptors are expressed in postnatal rat cochleas.
CAR and an, b3 and b5 integrin localization in rat cochlea
The cellular localization of CAR, and an, b3 and b5 integrins was investigated using immunofluorescence on P2 and P14 rat cochleas (Figure 1b-e) . In both ages studied, CAR and an integrin immunoreactivities were seen in mesothelial cells lining the scala tympani and the scala vestibuli. These proteins and b5 integrin were also expressed in cells on the scala tympani side of the basilar membrane and in the stria vascularis (Figure 1b , c, and e) In contrast, no b3 immunofluorescence was observed in these structures (Figure 1d ). The immunoreactivity to CAR and the three integrins was also localized to hair cell apical membrane and stereociliary bundles (Figure 1b-e). CAR and an, b3 and b5 integrins were expressed in supporting cells (pillar, Deiters' and Hensen's cells) and fibrocytes of the spiral ganglion (Figure 1b-e) . The three integrins but not CAR were expressed in spiral ganglion neurons (Figure 1b-e) . Finally, in P2 cochleas, CAR, an, b3 and b5 integrins were additionally expressed in Kö lliker's organ (not shown).
Gene transfer in the cochlea
In order to compare in vitro and in vivo gene transfer efficiency, concentrations of adenovirus were calculated so that the same number of particles were administered, that is, 2 Â 10 9 pp (see Table 1 ).
In vitro gene transfer in neonatal rat cochlear slices. Inoculation of rat cochlear slices resulted in GFP fluorescence in mesothelial cells lining the scala tympani and the scala vestibuli and Reissner's membrane (n ¼ 6; Figure 2a and b). Kö lliker's organ ( Figure  2b ) and in the organ of Corti, supporting that cells (border, phalangeal, Hensen's and Claudius' cells) expressed a GFP fluorescence (Figure 2b and c). Hair cells and the stria vascularis never exhibited GFP ( Figure  2b and c). In the spiral ganglion, GFP was expressed in fibrocytes, but not in neurons (Figure 2a and d) .
In order to disrupt tight junctions and facilitate the access of vectors into cells, cochlear slices were treated with ethylenediaminetetraacetic acid (EDTA, 250 mM). This treatment led to a general increase in GFP expression, but no new cell types expressed the transgene (not shown). In control slices treated with EDTA alone (without vectors), fluorescence intensity level in the organ of Corti was 4.0 a.u. (arbitrary units) 71.73 (n ¼ 5; Figure 2e ). Fluorescence intensity level in cochlea slices after adenovirus inoculation was 47.6 a.u.74.32 (n ¼ 5; Figure 2e ). When EDTA was added before and during adenovirus inoculation (Ad-EDTA), a significant (Po0.001) increase in the fluorescence level was observed (130.2 a.u.78.02, n ¼ 5; Figure 2e ). In the spiral ganglion, co-incubation of adenovirus with EDTA significantly (Po.001) increased GFP expression from 14.2 a.u.71.3 to 33.0 a.u.75.57 (n ¼ 5; Figure 2f ). Figure 1 Expression and localization of CAR and an, b3 and b5 integrin co-receptors in the cochlea. (a) PCR analysis of CAR, an, b3 and b5 integrins. On each panel, the products loaded were from left to right, as follows: positive control (+), negative control (À), cDNA amplified from P2 library, cDNA amplified from p14 library and DNA ladder (FX 174/HaeIII). Note that mRNAs coding for CAR, an, b3 and b5 integrins are expressed in the rat cochlea at both ages. The an integrin immunoreactivity was detected on the hair cell apical membrane and stereociliary bundles (arrows) and on the pillar heads. It was also present in the stria vascularis, the basilar membrane and the spiral ganglion. (d) b3 integrin immunostaining was observed on the hair cell apical membrane and stereociliary bundles (arrows) and in the spiral ganglion. (e) b5 integrin immunoreactivity was observed on the hair cell apical membrane and stereociliary bundles (arrows). It was also observed in the stria vascularis, the basilar membrane and the spiral ganglion. IHC, inner hair cell; OHCs, outer hair cells; Rm, Reissner's membrane; SM, scala media; ST, scala tympani; SV, scala vestibuli; sl, spiral limb; slg, spiral ligament; mc, mesothelial cells. Scale bars: left panels, 100 mm; right panels, 25 mm.
Adenovirus gene transfer in the mammalian cochlea F Venail et al Cells expressing GFP were counted on strips of organs of Corti to determine whether the GFP fluorescence increase was related to a change in the number and/or subtype of infected cells (Figure 2g ). In the preparation without EDTA (adenovirus alone), 78 cells76.07 were found to express GFP whereas after the EDTA treatment, 105.2 cells78.0 were GFP-positive (n ¼ 5 for each, Po0.05; Figure 2g ).
The role of CAR and anb3/anb5 integrins in cochlear gene transfer was then investigated by applying anti-CAR, anti-an or anti-CAR plus anti-an antibodies to the culture medium. In the organ of Corti, anti-CAR treatment significantly (Po0.001) decreased GFP fluorescence levels (16.6 a.u.71.5, n ¼ 5) compared with cochlear slices inoculated with the adenovirus alone (Figure 2e , 47.6 a.u.74.32, n ¼ 5). Fluorescence levels also decreased after anti-an or anti-CAR plus anti-an treatment. In these cases, the fluorescence levels were 8.8 a.u.71.24 (n ¼ 5) and 7.0 a.u.71.0 (n ¼ 5) for anti-an and for anti-CAR plus anti-an, respectively (Po0.001 for each; Figure 2e ). Counting the GFP-positive cells revealed that anti-CAR treatment significantly (Po0.001) decreased the number of infected cells in the organ of Corti (Figure 2g ): 21.8 cells73.37 versus 78 Compared to control slices, incubation with EDTA significantly increased the number of GFPpositive cells, whereas incubations with antibodies against CAR, an integrin or both significantly decreased it. There was no difference after incubation with anti-an integrin alone or an integrin plus anti-CAR. In (e-g), asterisks indicate significance and black dots the lack of significance (Student's t-test, significance level Pp0.05).
Adenovirus gene transfer in the mammalian cochlea F Venail et al cells76.07 after anti-CAR treatment (n ¼ 5) and adenovirus alone, respectively. The number of cells infected in the organ of Corti ( Figure 2g ) was also significantly reduced after anti-an (2.6 cells70.93; n ¼ 5, Po0.001) and anti-CAR plus anti-an (2.2 cells70.86; n ¼ 5, Po0.001). Anti-CAR treatment alone was less efficient in decreasing infection than anti-an alone or anti-an plus anti-CAR at the same dilution (Figure 2g ). The fact that there was no significant difference between anti-an alone or anti-an plus anti-CAR (P40.05 for fluorescence levels and for cell counting), and thus no additive effect (Figure 2g) (Figure 2f ).
In vivo gene transfer in adult rat cochlea. The efficacy of Ad5 DE1-E3/cytomegalovirus (CMV)/GFP in infecting cochlear cells was then studied in vivo using different protocols of inoculation. The first was based on peri-and endolymphatic perfusions, and the second evaluated the efficacy of adenovirus in transducing the cochlear cells after a single application with a syringe via a fenestra drilled in the basal turn of the scala tympani. Whichever method was used, no transduction was seen either in control cochleas that received artificial perilymph or endolymph, or in the contralateral ear of the inoculated animals (not shown).
Peri-and endolymphatic perfusions in vivo
No significant difference in compound action potential (CAP) audiograms was seen 3 days after perilymphatic perfusion in the control perilymph cochleas (n ¼ 5) and inoculated cochleas (n ¼ 5; Figure 3a ). Confocal microscopy examination (Figure 3a ) revealed that only those cells lining the perilymphatic spaces expressed GFP (i.e. the mesothelial cells of the scala tympani and scala vestibuli, the basilar and Reissner's membrane). No transduction occurred in cells in the organ of Corti, in the stria vascularis or the spiral ganglion (Figure 3a) . Endolymphatic perfusion resulted in CAP threshold elevations, predominantly in the low frequencies of the audiograms, in both the control endolymph cochleas (n ¼ 5) and inoculated cochleas (n ¼ 5; Figure 3b ). Transgene expression was seen in the cells lining the scala media (i.e. Reissner's membrane and basilar membrane, Figure 3b ). Hensen's, Deiters', pillar and phalangeal cells (Figure 3b ) and the satellite cells surrounding the spiral ganglion neurons (Figure 3b ) were clearly transduced, but not the sensory hair cells (Figure 3b ) nor the strial cells (Figure 3b ).
Syringe injection into the basal turn of the scala tympani in vivo. A single dose administered with a microsyringe into the perilymph of the scala tympani induced dramatic CAP threshold elevations across all frequencies, both in the control and inoculated cochleas (Figure 3c ). This is most probably owing to rupture of ear membranes. Indeed, GFP expression was present in a pattern that was a mixture of that observed after perilymphatic and endolymphatic perfusion (Figure 3c ), except in one cochlea in which fluorescence signal was restricted to the mesothelial cells of the scala tympani. In contrast to previously results, transgene expression was seen in some inner and outer hair cells (Figure 3c ) and in some of the strial cells in two out the six cochleas ( Figure  3c ). To determine whether CAR and integrin receptors are involved in cochlear gene transfer, we injected the adenovirus 10 min after a preadministration of anti-CAR plus anti-an (n ¼ 6). Only some mesothedial cells of the scala tympani, some cells of the basilar membrane and some spiral ganglion fibrocytes expressed GFP in the antibody pretreated cochleas. No GFP expression was seen in the organ of Corti. Fluorescence levels were respectively 113.20 a.u.715.53 versus 3.80 a.u.71.71 in organ of Corti in antibody pretreated and non-pretreated cochleas (Figure 3d ). In the spiral ganglion, GFP expression was significantly (Po0.01), but not completely, decreased with fluorescence levels of 51.60 a.u.73.49 versus 37.60 a.u.73.20 in pretreated and non-pretreated cochleas (Figure 3d) .
Discussion
Our results demonstrate that the majority of cochlear cells expressing CAR and an integrins can be transduced by Ad5 DE1-E3/CMV/GFP. The number and the subtype of cells transduced is dependant on the mode of adenovirus administration. Although the sensory hair cells and strial cells express CAR and an integrins, they could not be transduced in vitro or after peri-or endolymphatic perfusions in vivo. However, occasional transduction into sensory hair cells and strial cells was seen after a single microsyringe dose to the perilymph. Spiral ganglion neurons, which only express integrin co-receptors, were never infected.
CAR and anb3/anb5 integrin co-receptors in cochlear gene transfer
To study the role of CAR and anb3/anb5 integrin coreceptors in cochlear gene transfer, we compared the pattern of receptor expression with the pattern of cells infected by the adenovirus. CAR and an integrin receptors were present in every cell subtype that had been transduced by the adenoviral vector. Although sensory hair cells and strial cells were sometimes transduced in vivo after adenovirus syringe injection, no transduction was seen after peri-or endolymphatic perfusion in the sensory hair and strial cells. This suggests that expression of CAR or integrins is not completely predictive of adenoviral transduction in the cochlear cells. In other tissues, improved transfection efficiency is achieved both in vivo and in vitro by the use of EDTA, which is known to open tight junctions. 19, 20 In the present study, improving the accessibility of the receptors with EDTA in vitro leads to an increase in transgene expression in cells targeted by the vector, although the influence of EDTA on tight junctions (direct or not) is still unknown in the cochlea. Whatever the mechanism involved, the increased infection with EDTA supports the hypothesis that disrupting tight junctions allows better access to the viral receptors. Consistently, Adenovirus gene transfer in the mammalian cochlea F Venail et al 
Cellular barriers to adenovirus-mediated gene transfer
In contrast to most of the cochlear cell subtypes that express adenovirus receptors on the basolateral surface of the membrane, sensory hair cells express CAR, anb3 and anb5 integrins at their apical pole. Localization of these receptors at this site may explain, at least in part, the difficulties encountered in attempting successful gene transfer into the sensory hair cells. In infected polarized Madin-Darby canine kidney cells or human epithelial airway cells, those expressing apical CAR were not efficiently transduced by adenovirus applied to the apical surface. 22, 23 However, after the cells were treated with agents that remove components of the apical surface glycocalyx, adenovirus transduction occurred, suggesting that glycocalyx impedes the interaction of adenovirus with apical receptors. One can thus speculate that binding receptors located on the apical pole of the sensory hair cells may be significantly impaired by the glycocalyx that surrounds the stereocilia bundles, 24 even when the adenovirus was administered anatomically close to the sensory hair cells (i.e. in the endolymph). In our experiments, even disruption of the tight junctions (with EDTA) did not permit transduction of sensory hair cells or strial cells. Further research is needed to elucidate the function of those CAR and integrin coreceptors that are located on the apical face and the stereocilia bundles of the sensory hair cells.
Efficiency and safety of gene transfer in vivo
The cochlea is divided into two fluid-filled compartments, the endolymphatic and the perilymphatic spaces. The barrier between the two is composed of apical membranes of cells of the membranous labyrinth and the tight junctions between them. Viral perfusion into perilymphatic spaces transduced cells lining this target compartment. Perfusion into the endolymph transduced the supporting cells of the organ of Corti, but not the cells lining the perilymphatic spaces. This result indicates that adenoviruses do not pass through the perilymphendolymph barrier, as previously shown in guineapigs. 4, 6 This would support the findings of Kawamoto et al., 25 who showed that in vivo inoculation of adenovirus containing Math1 gene into the endolymph of the mature guinea-pig cochlea results in Math1 overexpression in non-sensory cochlear cells, as evident from the presence of Math1 protein in the supporting cells of the organ of Corti and in adjacent non-sensory epithelial cells. We have further shown that inoculation of the adenovirus into the scala tympani with a syringe causes a drastic threshold shift, predominantly in the low frequencies. However, the control experiments with artificial perilymph induced similar threshold shifts to those caused by the adenovirus injection, and so we conclude that the hearing disturbance caused by a single shot microsyringe injection is due to the damaging effect of the method of administration rather than to the virus itself. It is thus possible that animals exhibited transduction into cells of the scala media because a rupture of the basilar or Reissner's membrane had occurred, which in turn allowed the viral particles to reach the endolymph. In addition to membrane disruption, the lack of a perfusion outlet probably creates pressure damage in the apical portion of the cochlea, as the endolymphatic space is smaller here; this is consistent with the lowfrequency threshold shifts that we noted. However, the fact that some sensory hair cells and strial cells were transduced in two of the six animals injected cannot be explained by direct access of the adenovirus to the cells along as no GFP expression was seen in the sensory hair cells when the same number of particles was applied to cochlear slices or directly into the endolymph. Although the total number of viral particles was the same, different concentrations were applied in the different experiments (see Table 1 ). The concentration used for application by microsyringe was 100 times higher than the concentration used in vitro, and 10 times higher than the calibrated perfusion in vivo. Finally, the lack of reliability of viral transduction with microsyringe inoculation leads to the proposal that non-controlled parameters, such as damage and/or increased pressure, may facilitate the access of the virus to receptors present on sensory hair cells and strial cells, and consequently may permit their transduction. Indeed, gene expression in the sensory hair cells and strial cells has previously been reported using the same syringe inoculation protocol. 10 Intriguing, however, are the results of Luebke et al., 8, 9 who reported that 7 days of delivery of adenovirus into the basal turn perilymph via an osmotic minipump led to preservation of hearing and b-gal expression specifically in the sensory hair cells, but not into the adjacent structures such as the supporting cells. In Accordance with Ishimoto et al., 6 who was unable to replicate this result, we suggest that the method used to detect b-gal expression may account for this unexpected result. In contrast to guinea-pigs, 26 no contralateral transfection of cochlear cells was presently found in rats. The difference between the two studies could be owing to the size of cochlear aqueduct in both species, the volumes injected (25 ml in guinea-pigs versus 5 ml in rats) or the methods of transgene detection (b-gal versus GFP in the present study).
Conclusions
Our study demonstrates that the CAR/an integrin coreceptor pathway is involved in adenovirus gene transfer in the cochlea and that the accessibility of those receptors is a limiting factor for the efficiency of the transduction. In addition to having a better understanding of celladenovirus interaction in the cochlea, we highlight the need for an efficient in vivo delivery method for the adenovirus to reach the organ of Corti.
Materials and methods
PCR on rat cochlea cDNA library P2 and P14 rat whole cochlea cDNA libraries were constructed as described elsewhere. 27 Specific primers for CAR (F: 0 , R: 5 0 -ggctttgtacattctggcatgtgc-3 0 ) were used in the PCR reaction. The PCR products were separated on a 1% agarose gel. The bands were cut from the gel, DNA was extracted and purified by centrifugation filtering (Amicon; Amplicon, Brighton, UK) and then sequenced with an automated sequencer (ABI Prism 310; Applied Biosystems, Foster City, CA, USA). All sequences were compared with sequences of GenBank using basic local alignment search tool. 28 Positive controls used in these reactions were reverse transcriptase-polymerase chain reaction products from adult rat lung (CAR, an integrin), liver (b3 integrin) and bowel (b5 integrin).
Immunocytochemistry
Adenovirus receptor and co-receptors were localized using rabbit antibodies against CAR (1/10 000, gift from Dr Kremer -CNRS 5535, Montpellier, France), integrin an, integrin b3 and integrin b5 (1/5000 each, Chemicon, Temecula, CA, USA). Double-labeling was performed on 10-mm-thick cryostat sections of P2 and P14 rat cochleas using a mouse anti-parvalbumin (1/750, Sigma-Aldrich, St Louis, MO, USA) to counterstain hair cells and auditory neurons. Hair cells and neurons in inoculated rat cochlea slices were labeled using goat antibodies against calbindin (1/100, Chemicon) and mouse antiNF200kD (1/2000, Sigma-Aldrich), respectively. Donkey anti-goat IgG-Alexa 647 and anti-mouse-Alexa 594 (1/ 500, Molecular Probes, Eugene, OR, USA) were used to localize these proteins, whereas CAR, integrin an, b3 and b5 were detected using a fluorescein isothiocyanatetyramide amplification step (PerkinElmer, Wellesley, MA, USA). The sections were examined with a Bio-Rad MRC1024 laser scanning confocal microscope.
Viral vectors
The vector used was a replication-deficient human serotype 5 adenovirus deleted in E1 and E3 region and carrying the GFP gene driven by CMV) promoter (Ad5 DE1-E3/CMV/GFP, gift from Dr Zuliani, Genethon, Evry, France). Vectors were aliquoted at 4 Â 10 12 pp/ml in 30% sucrose and stored at À801C until used.
Gene transfer on cochlear slices
Cochlear slice technique was adapted from Jagger et al.
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After cutting on the vibratome, 300-mm-thick cochlear slices from newborn rat (P2-P5) were placed on membrane culture inserts (Falcon, Rockville, MD, USA) and cultured in six-well plates with modified Dulbecco's modified Eagle's medium (DMEM Gibco, D-glucose 6 g/l, L-glutamine 4 mM, N1, penicillin 30 U/l, 10% CFS; Invitrogen, Carlsbad, CA, USA) in an incubator (371C, 5% CO 2 ). Tight junction disruption was performed by treating the slices with 250 mM EDTA for 30 min in Hank's balanced salt solution with no Ca 2+ (n ¼ 5). The type of adenovirus receptors involved was studied by using anti-CAR (dilution 1/1000; n ¼ 5), anti-an integrin (dilution 1/1000; n ¼ 5) or anti-CAR plus anti-an integrin (dilution 1/1000 for each; n ¼ 5) antibodies in DMEM. After 18 h, specimens were fixed with 4% paraformaldehyde in phosphate buffer saline for half an hour.
Cochlear gene transfer in vivo
Animal care and handling followed the animal welfare guidelines of the 'Institut National de la Santé et de la Recherche Médicale' (INSERM), under the approval of the French 'Ministère de l'Agriculture et de la Forêt'. Adult Wistar rats were anesthetized with an intraperitoneal injection of sodium pentobarbital 4% (0.4 ml/kg; Sanofi, Paris, France) and 12.5 mg of atropine 1% (Aguettant, Lyon, France).
Peri-and endolymphatic perfusions in vivo. We developed a new surgical approach for our perfusion technique in rat cochleas. For perilymphatic perfusion, a small hole (0.1 mm) was manually drilled in the scala tympani just below the stapedial artery. A second hole in the scala vestibuli of the basal turn allowed the perfused solution to exit the cochlea (see Figure 3a) . Preservation of hearing was confirmed by recording auditory brainstem responses before and after drilling the hole (n ¼ 5). For endolymphatic perfusion, a small fenestra was shaved in the cochlear bony capsule of the first turn over the stria vascularis (which had a white appearance in the Wistar rat, see Figure 3b ). Here, the second hole was made at the cochlear apex. Endocochlear potentials were recorded to ensure the correct positioning of the hole. Only those animals with normal endocochlear potentials after this procedure (92.2 mV71.4, n ¼ 5) received adenoviruses through this scala media fenestration.
Depending on the compartment perfused, vectors were diluted in artificial perilymph or artificial endolymph, and solutions were perfused through a hole in the basal turn, and flowed out of the cochlea through a hole at the apex. The artificial perilymph solution had the following composition (in mM): 137 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 1 NaHCO 3 , 11 glucose and 10 N-2-hydroxyethylpiperazine-N 0 -2-ethane sulfonic acid. Artificial endolymph composition was NaCl 1 mM, KCl 126 mM, KHCO 3 25 mM, MgCl 2 0.025 mM, CaCl 2 0.025 mM and K 2 HPO 4 1.4 mM. The pH was 7.4 and osmolarity maintained at 300 mOsm/kg H 2 O.
Single shot with a microsyringe in vivo. Injection of 5 ml of adenoviral solution in artificial perilymph was performed with a microsyringe through one hole made in the basal turn of the scala tympani. No hole was made at the apex. For antibody pretreatments, a dilution of anti-CAR plus anti-an (1/1000 each, 5 ml) in artificial perilymph was applied 10 min before and during the vector injection. The hole made in the basal turn was sealed with Horsley wax and the bulla was closed with dental cement. The skin incision was sutured and teramycine (120 mg/kg; Pfizer, Ixelles, Belgium) was administrated as prophylaxis.
Fluorescence evaluation and cell counting
Image analysis was performed with Image J1.34 software (National Institute of Health, USA). GFP fluorescence level measurements were performed in vitro and in vivo using a histogram function in a 200 Â 100 pixel box focused on several organs of Corti or spiral ganglions, which were identified by merging light microscopy images with projections of fluorescence microscopy. For each organ of Corti or spiral ganglion analyzed, 
Auditory functional assessment
Three days later, the animals were re-anesthetized, mounted in a head-holder with Bruel and Kjaer microphone (type 4134) ear bars, and an electrode was placed on the round window. Compound action potentials (CAPs) of the auditory nerve were elicited by tone bursts of alternating polarity (1 ms rise/fall, 8 ms duration) applied to the ear at a rate of 10 per second from 0 to 100 dB SPL in 5 dB steps. The threshold of the CAP was defined as the intensity in dB SPL needed to elicit a measurable response (X2 mV).
